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BACKGROUND: Among polyphenolic compounds suggested to prevent
cardiovascular diseases (CVDs) and to explain the "French paradox", the
anthocyanidin delphinidin (Dp) has been reported to support at least partly the
vascular beneficial effects of dietary polyphenolic compounds including those from
fruits and related products as red wine. It has also been highlighted that Dp
interacts directly with the active site of estrogen receptor α (ERα), leading to
activation of endothelial NO synthase (eNOS) pathway thus contributing to the
prevention of endothelial dysfunction in mice aorta. However, anthocyanidins have
very low bioavailability and despite a well described in vitro efficacy, the very high
hydrophilicity and physicochemical instability of Dp might explain the lack of in
vivo reported effects.
OBJECTIVE: The aim of this study was to identify new Dp analogues with
increased lipophilicity and vasorelaxation potential by a chemical modulation of its
structure and to characterize the signaling pathway notably in relation with ERα
signaling and nitric oxide (NO) production.
METHOD: OCH3-substituted delphinidin analogues were obtained through the
coupling of the corresponding acetophenones with substituted benzaldehydes.
Prediction of resorption of the flavylium derivatives was performed with the
calculated logP and induction of vasorelaxation was performed by myography on
WT and ERαKO mice thoracic aorta rings and compared to Dp. NO production was
evaluated in vitro on human primary endothelial cells.
RESULTS: Eight Dp analogues were synthesized including four new flavylium
derivatives. Two compounds (9 and 11) showed a strong increase of vasorelaxation
potential and a theoretically increased bioavailability compared to Dp.
Interestingly, 9 and 11 induced increased O2 - or NO endothelial production
respectively and revealed a novel NO-dependent ERα-independent relaxation
compared to Dp. We suggested that this mechanism may be at least in part
supported by the inhibition of vascular cyclic nucleotide phosphodiesterase
(PDEs).
CONCLUSION: The current study demonstrated that pharmacomodulation of the
Dp backbone by replacement of OH groups by OCH3 groups of the A and B rings
led to the identification and characterization of two compounds (9 and 11) with
enhanced physio-chemical properties that could be associated to higher
permeability capability and pharmacological activity for the prevention of CVDs
compared to Dp.
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